GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,860,565 | +11.8% | 984,100 | +34.1% | 2.80% | +12.0% |
| Q2 2023 | $43,708,314 | +8.1% | 734,100 | +2.8% | 2.50% | -6.6% |
| Q1 2023 | $40,446,624 | -19.0% | 714,100 | +6.2% | 2.68% | -18.8% |
| Q4 2022 | $49,939,148 | +22.6% | 672,400 | -1.6% | 3.30% | +12.9% |
| Q3 2022 | $40,717,000 | +5.4% | 683,500 | -0.7% | 2.93% | +11.7% |
| Q2 2022 | $38,624,000 | -24.7% | 688,000 | -1.1% | 2.62% | -5.4% |
| Q1 2022 | $51,306,000 | +8.6% | 695,400 | +6.3% | 2.77% | +31.4% |
| Q4 2021 | $47,226,000 | +0.2% | 654,100 | +6.4% | 2.11% | -13.0% |
| Q3 2021 | $47,122,000 | -0.1% | 615,000 | +1.1% | 2.42% | +7.2% |
| Q2 2021 | $47,146,000 | +27.3% | 608,100 | +1.3% | 2.26% | +17.9% |
| Q1 2021 | $37,021,000 | -2.4% | 600,300 | +3.2% | 1.92% | -15.4% |
| Q4 2020 | $37,939,000 | +28.3% | 581,700 | -2.6% | 2.27% | -8.8% |
| Q3 2020 | $29,578,000 | +5.1% | 597,300 | +1.3% | 2.49% | -3.6% |
| Q2 2020 | $28,140,000 | -6.3% | 589,800 | -16.5% | 2.58% | -28.9% |
| Q1 2020 | $30,030,000 | -45.7% | 706,100 | -24.8% | 3.63% | -15.0% |
| Q4 2019 | $55,312,000 | +15.2% | 939,400 | +0.1% | 4.26% | -0.8% |
| Q3 2019 | $47,997,000 | +20.1% | 938,900 | -0.6% | 4.30% | +17.9% |
| Q2 2019 | $39,960,000 | +10.3% | 944,700 | +28.8% | 3.64% | +14.4% |
| Q1 2019 | $36,243,000 | +14.2% | 733,500 | 0.0% | 3.18% | +2.2% |
| Q4 2018 | $31,746,000 | -23.6% | 733,500 | +0.2% | 3.12% | -4.7% |
| Q3 2018 | $41,560,000 | +12.0% | 732,200 | -0.4% | 3.27% | +9.2% |
| Q2 2018 | $37,113,000 | +1.3% | 735,500 | 0.0% | 2.99% | -3.5% |
| Q1 2018 | $36,643,000 | +21.2% | 735,500 | 0.0% | 3.10% | +20.2% |
| Q4 2017 | $30,229,000 | +37.6% | 735,500 | -0.5% | 2.58% | +35.6% |
| Q3 2017 | $21,963,000 | -15.7% | 739,000 | -6.0% | 1.90% | -18.8% |
| Q2 2017 | $26,059,000 | +10.8% | 786,100 | -1.0% | 2.34% | +5.9% |
| Q1 2017 | $23,516,000 | -7.9% | 793,900 | -22.8% | 2.21% | -10.8% |
| Q4 2016 | $25,528,000 | +11.9% | 1,028,900 | +1.8% | 2.48% | +3.8% |
| Q3 2016 | $22,808,000 | -0.4% | 1,010,575 | +5.2% | 2.39% | -14.3% |
| Q2 2016 | $22,901,000 | +1.2% | 961,000 | +0.9% | 2.79% | +6.0% |
| Q1 2016 | $22,622,000 | -14.4% | 952,500 | +0.3% | 2.63% | -10.6% |
| Q4 2015 | $26,415,000 | +39.9% | 949,500 | +3.9% | 2.94% | +28.2% |
| Q3 2015 | $18,877,000 | -16.8% | 913,700 | +3.3% | 2.30% | -2.0% |
| Q2 2015 | $22,700,000 | +4.5% | 884,325 | +2.7% | 2.34% | +4.6% |
| Q1 2015 | $21,726,000 | +2.0% | 860,750 | -3.9% | 2.24% | +6.8% |
| Q4 2014 | $21,295,000 | +9.8% | 895,900 | -9.2% | 2.10% | +30.1% |
| Q3 2014 | $19,397,000 | -2.8% | 986,150 | +18.2% | 1.61% | +9.0% |
| Q2 2014 | $19,957,000 | +21.2% | 834,325 | +34.7% | 1.48% | +24.5% |
| Q1 2014 | $16,469,000 | +21.8% | 619,350 | -7.5% | 1.19% | +46.4% |
| Q4 2013 | $13,516,000 | +52.9% | 669,800 | +32.3% | 0.81% | +52.0% |
| Q3 2013 | $8,837,000 | +2.4% | 506,100 | -1.2% | 0.54% | +32.8% |
| Q2 2013 | $8,634,000 | – | 512,100 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |